Slide 1 of 19 Rob Packard, President

Slides:



Advertisements
Similar presentations
What’s New in Knee Replacement
Advertisements

Regulation of Medical Devices Celia M. Witten, Ph.D., M.D. Director Division of General, Restorative and Neurological Devices Office of Device Evaluation.
Hip Arthroplasty.
"Determining the Regulatory Pathway to Market" Classification Heather S. Rosecrans Director, 510(k) Staff Office of Device Evaluation Center for Devices.
Advanced Treatment Options for Knee Arthritis Surgeon Name Clinic Name Clinic Address Phone Number Web Address.
Strengthening the Medical Device Clinical Trial Enterprise
Testing Your Device: What the FDA Looks For
Public Health Issues Related to Mutually Conforming Labeling: CDRH Perspective Miriam C. Provost, Ph.D. Office of Device Evaluation Center for Devices.
510k Submission Overview Myraqa, Inc. August 22, 2012.
Hogan & Hartson L.L.P. \\\71717/ v1 Slide 1 FDA Public Meeting David M. Fox Hogan & Hartson LLP (202) Regulation of.
Combining Product Risk Management & Design Controls
FDA Pre-Submission Meetings for 510(k) Submissions
The Perspectives and Expectations on Medical Device Application from Taiwan High-Tech Industry Anita Chen Ophthalmic Medical Device.
PURPOSE OF DFMEA (DESIGN FAILURE MODE EFFECTS ANALYSIS)
Accelerating Product Development June 25, 2015 IMDMC REG 101 Pathways To Market.
Medical Devices Approval Process
An analysis of human movement: Joints, Muscles and Mechanics in specified sporting actions (including planes and axes) What you need to know: Analyse shoulder.
Slide 1 of 21 Robert Packard, President Supplier Auditing & Remote Auditing.
Rob Packard, President Slide 1 of 23 Bioburden Failure Analysis An E. coli strain being plated for identification.
Rob Packard, President Slide 1 of 30 Bioburden Failure Analysis An E. coli strain being plated for identification.
Slide 1 of 11 April 2014 Rob Packard, President Regulatory Pathways 101: Your 1 st Product Launch in Canada,
+ Medical Devices Approval Process. + Objectives Define a medical device Be familiar with the classification system for medical devices Understand the.
Research & Innovation Horizon societal challenge 1 Open Info Day Funding Opportunities for SMEs Horizon 2020 "Health, demographic change and wellbeing"
Codex Guidelines for the Application of HACCP
Tina Morrison, PhD Advisor of Computational Modeling
IPhVWP Polish Presidency, Warsaw October 6 th 2011 Almath Spooner Irish Medicines Board Monitoring the outcome of risk minimisation activities.
1 THE UNIQUE ROLES OF IRB IN MEDICAL DEVICE CLINICALL TRIAL Chiu Lin, Ph.D. CITI, May, 2009 CITI, May, 2009.
The Medical Device Pathway as a Legal Onramp for Futuristic Persons THE FUTURE T HE M EDICAL D EVICE P ATHWAY AS A L EGAL.
Creating a Risk-Based CAPA Process
Slide 1 of 22 Rob Packard, President 510(k) Project Management.
Dr. Pete Rose Joint Replacement. Total = Ball + Socket.
Slide 1 of 20 Rob Packard, President FRM-023 A D1 – Management Review Template Management Review Management.
IPhVWP Polish Presidency, Warsaw October 6 th 2011 Almath Spooner Irish Medicines Board Monitoring the outcome of risk minimisation activities.
Product Development Chapter 6. Definitions needed: Verification: The process of evaluating compliance to regulations, standards, or specifications.
OIVD Workshop Premarket Notification (510(k)) April 22, 2003 Parklawn Building Rockville, MD Presented by Marjorie Shulman Premarket Notification Staff.
Regulatory Challenges for the Wireless Health Industry Kathy Chester, Sr. V.P., Regulatory Affairs & Quality Assurance St. Jude Medical Cardiac Rhythm.
Total Hip Arthroplasty BME 181 By: Erik Walder. What is total hip arthroplasty? Total Hip Replacement Bone is sheared away and an artificial hip is implanted.
Humanitarian Use Devices September 23, 2011 Theodore Stevens, MS, RAC Office of Cellular, Tissue and Gene Therapies Center for Biologics Evaluation and.
510(k) Submissions Recent Experience and Perspectives Terry Sullivan Vice President, Regulatory Affairs.
REGULATORY HISTORY OF CPR DEVICES
1 Medical Imaging & Technology Alliance MITA Perspective on Establishing a Public Database for Device Labeling & Photos CDRH Public Meeting April 7, 2011.
UHMWPE Superalloy Polyethylene Cemented & Uncemented
Categories of Biomaterials
Food safety Training Course Co-financiado:. Thermopar Bimetallic thermometer Digital Infra-red.
International Atomic Energy Agency Roles and responsibilities for development of disposal facilities Phil Metcalf Workshop on Strategy and Methodologies.
Utah Life Science Summit Nov Phil Triolo, PhD RAC President, Phil Triolo and Associates LC.
UPCOMING CHANGES TO IN-VITRO DIAGNOSTICS (IVDs) AND LABORATORY DEVELOPED TESTS (LDTs) REGULATIONS Moj Eram, PhD November 5, 2015.
The 510(k) Program Roy Baby, Investigator US Food & Drug Administration 4040 N Central Expressway, Dallas, TX 1.
Product Labels.
GU Advisory Panel Meeting Nocturnal Home Hemodialysis Draft Carolyn Y. Neuland, Ph.D. Chief, Gastroenterology and Renal Devices Branch Division of Reproductive,
AMERICAS | ASIA PACIFIC | EMEA Medical Devices: Concept to Commercialization How to avoid delays in getting your product cleared/approved by FDA Robert.
Radiology Advisory Panel Meeting Radiology Advisory Panel Meeting Computer-Assisted Detection (CADe) Devices Joyce M. Whang Deputy Division Director Radiological.
Locking Plates: Tips and Tricks by Wade R. Smith, Bruce H. Ziran, Jeff O. Anglen, and Philip F. Stahel J Bone Joint Surg Am Volume 89(10): October.
The CDRH Software Message (October 19, 2002) John F Murray Jr.. Center for Devices & Radiological Health US Food and Drug Administration
In the name of God. Common Technical Document On Biotech.
Division of Cardiovascular Devices
Premarket Notification 510(k) process
FDA’s IDE Decisions and Communications
Balancing Regulation and Innovation: An FDA Division of Cardiovascular Devices Perspective Bram Zuckerman, MD, FACC Director, FDA Division of Cardiovascular.
Reasonable Assurance of Safety and Effectiveness: An FDA Division of Cardiovascular Devices Perspective Bram Zuckerman, MD, FACC Director, FDA Division.
FDA Guidance on Early Feasibility Studies, Including First-in-Human
Calcified Lesion and Device Intervention Across the Pacific: PMDA View
Introduction of New Technology: An FDA Division of Cardiovascular Devices Perspective Bram Zuckerman, MD, FACC Director, FDA Division of Cardiovascular.
Medical Device Premarket Submission Challenges and the Effect of MDUFA IV Robin Fatzinger, RAC VP, Regulatory Affairs Aesculap
with Audrey Turley, B.S., RM (NRCM), CBA (ASQ)
Fracture of shaft of femur
Linda M. Chatwin, Esq. RAC Business Manager, UL LLC
A Practical Introduction to the Clinical Evaluation Report
Tibial plateau fracture
Presentation transcript:

Slide 1 of 19 Rob Packard, President

Slide 2 of 19 Rob Packard, President Agenda New FDA guidance & flow chart Intended Use Technological Characteristics Split Predicates Multiple Predicates Examples Reference Device Presentation of Equivalence Data

Slide 3 of 19 Rob Packard, President Most Critical Sections 4 – Indications for Use (1 st ) (k) Summary (4 th ) 10 – Executive Summary (my last) 11 - Device Description (2 nd ) 12 – Substantial Equivalence (3 rd ) RTA Checklist is a great quality 

Slide 4 of 19 Rob Packard, President How FDA Evaluates SE?

Slide 5 of 19 Rob Packard, President 6 Questions 1.Is the predicate device legally marketed? 2.Do the devices have the same intended use? 3.Do the devices have the same technological characteristics? 4.Do the different technological characteristics raise different questions of safety and effectiveness? 5.Are the methods of evaluating new/different characteristics acceptable? 6.Does the data demonstrate substantial equivalence?

Slide 6 of 19 Rob Packard, President Legally Marketed? Registration and listing database A 510(k) is not enough!

Slide 7 of 19 Rob Packard, President Same Intended for Use? Compare with Applicable Regulation Compare with Primary Predicate Carefully Justify Differences with Subject Device – More Narrow Scope – Broader Scope

Slide 8 of 19 Rob Packard, President Technological Characteristics? Materials Design Energy Source Other Features Same ≠ Equivalent – Does not raise DIFFERENT issues of safety or effectiveness – Must be as safe and effective as predicate

Slide 9 of 19 Rob Packard, President Split Predicates 1 st Predicate has same intended use 2 nd Predicate has same technological characteristics This is not allowed.

Slide 10 of 19 Rob Packard, President Multiple Predicates Allowed… Option 1: – Two predicates with different technological characteristics, but the same intended use Option 2: – A device with more than one intended use Options 3: – More than one indication under the same intended use

Slide 11 of 19 Rob Packard, President Examples Example 1 – Hemodialysis catheter – Predicate A has same extension design – Predicate B has same tip design – Both A & B predicates have the same intended use Example 2 – Fracture fixation plate – Predicate A is indicated for middle bone fractures – Predicate B is indicated for bone tip fractures – Both A & B predicates are intended for long bone fractures – New performance testing may be required

Slide 12 of 19 Rob Packard, President Examples (continued) Example 3 – Laser hand piece – Predicate A Er:YAG laser hand piece – Predicate B Q-Switch Nd:YAG laser hand piece – Both A & B predicates have the same general intended use of lasers: “incision, excision, ablation, vaporization of soft tissue.” – New performance testing may be required – A single predicate could have been used, but the inclusion of a second predicate is helpful in establishing substantial equivalence with regard to specific indications and technological characteristics.

Slide 13 of 19 Rob Packard, President Examples (continued) Example 4 – Multi-parameter monitor – New monitor includes different technologies – Predicate for each parameter – Monitoring of each parameter cannot interfere with the others – New performance testing may be required

Slide 14 of 19 Rob Packard, President Examples (continued) Example 5 – Temperature measuring urinary catheter – Urinary catheter is primary predicate – Thermometer is secondary predicate added as a convenience – Two predicates fall under different classifications – The additional feature cannot alter the risk profile of the urinary catheter

Slide 15 of 19 Rob Packard, President Use of Reference Device Must first pass decision point questions 1-4 Example of a knee implant with a new coating: – Predicate is a legally marketed – Predicate has the same intended use – Predicate has different technological characteristics (i.e., the coating) – Predicate and subject device have the same questions of safety & effectiveness (i.e., biocompatability)

Slide 16 of 19 Rob Packard, President Why Questions 1-4 first? Predicate = Metal-Ceramic Total ShoulderSubject Device = Metal-Ceramic Total Knee 1. Yes legally marketed deviceN/A 2. Intended use for resurfacing joint 3. Semi-constrained ceramic humeral ball on a cobalt chrome shaft wearing against a cobalt chrome glenoid articulating surface 3. Semi-constrained femoral head made of ceramic wearing against cobalt chrome tibial plateau 4. No weight bearing function of a total shoulder and metal shalt supporting ceramic ball; less likely to fracture ceramic 4. Weight bearing function of a total knee and no metal supporting ceramic femoral head; more likely to fracture ceramic requires greater loading during cyclic testing The different risks associated with the different indications for use and the fact that the fixation of the two ceramic articulating surfaces is very different make it impossible to say that the devices do not present different risks. The conclusion would be NSE and a reference device for cyclic testing would be irrelevant.

Slide 17 of 19 Rob Packard, President Equivalence Data Intended Use Technological Characteristics – Materials, Design, Energy Source, Other Features Performance Data – Biocompatibility – Electrical Safety & Electromagnetic compatibility (EMC) – Software verification and validation – Mechanical and acoustic testing – Animal Study – Clinical Study

Slide 18 of 19 Rob Packard, President Q & A

Slide 19 of 19 Rob Packard, President Need a quotation for a 510(k) Submission? Rob Packard rob13485